Almost two in three Norwegians want to receive the coronary vaccine – NRK Norway – Summary of news from different parts of the country

There is a common struggle around the world to find a vaccine against the coronavirus.

In various laboratories around the world, a number of research projects are underway and there are many indications that we are getting closer to approval of the first coronary vaccine.

According to Bent Høie, the first doses in Norway will be available at best early in the new year.

Opinion’s Norwegian coronary monitor has asked 1,400 Norwegians if they want to receive such a vaccine against coronavirus when it arrives.

Up to 63 percent answer yes, 16 percent answer no, while 22 percent are still unsure.

– A clear majority want to get the coronary vaccine when they arrive, but far from everything. In any case, it is not very clear when the vaccine will arrive, who will receive it and how it works, says senior adviser Nora Clausen in Opinion.

The study shows that men want to be vaccinated more than women.

It also appears that the proportion who want to be vaccinated is higher among those over 60 years of age.

Many people are concerned about side effects.

Although nearly two in three Norwegians say they want to get vaccinated against the coronavirus, many are very concerned that a vaccine could cause unfortunate side effects.

In the survey, up to 60 percent say they are afraid of this.

The concern is highest among women and those in their 30s and 60s, and lowest among those over 60.

Get vaccinated through Sweden

Sweden has ensured that Norway will have access to the so-called Oxford vaccine through an agreement with the EU if the vaccine is approved.

The researchers behind the vaccine so far have not discovered any side effects.

Now, however, they will enter a new phase in which many more people will be tested. It is not yet known if this means that unfortunate side effects can occur.